J M Smith acquires Integra NV business
J M Smith Corp. has acquired pharmacy-related technology products and services offered by Integra NV and will manage them as a subsidiary called Integra LTC Solutions LLC.
J M Smith Corp. has acquired pharmacy-related technology products and services offered by Integra NV and will manage them as a subsidiary called Integra LTC Solutions LLC.
Sanofi and the life sciences team at Google have formed a collaboration to improve care and outcomes for people with type 1 and type 2 diabetes.
NeilMed Pharmaceuticals Inc. USA has rolled out the Naspira nasal-oral aspirator for babies and small children.
Perrigo Co. plc has acquired the ScarAway scar management brand from Enaltus LLC. Financial terms of the transaction weren’t disclosed. Perrigo said Monday that Scaraway is expected to generate overall 2015 net sales of $10 million, or approximately $3 million for the remainder of the year.
Early feedback on the Food and Drug Administration’s proposal on naming conventions for biosimilars shows a mixed response.
Head & Shoulders has signed up New York Giants wide receiver Odell Beckham as its latest hair ambassador. The Procter & Gamble hair care brand — the official shampoo of the National Football League — said Friday that fans can now see Beckham in his first ad for Head & Shoulders on the
Novo Nordisk plans to acquire Calibrium LLC and MB2 LLC, two privately held biopharmaceutical research companies based in Carmel, Ind.
Beauty care manufacturer and distributor American International Industries (A.I.I.) has acquired Hollywood Fashion Secrets, a brand of fashion and beauty accessories. Financial terms of the agreement, announced Thursday, weren’t disclosed.
Aurobindo Pharma Ltd. has gained approval from the Food and Drug Administration for entecavir tablets 0.5 mg and 1 mg, a medication for hepatitis B. Aurobindo, which announced the product this week, said its entecavir tablets are a generic version of Baraclude tablets (0.
Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Co. have received approval from the Food and Drug Administration for Synjardy tablets, a medication for type 2 diabetes.
Alvogen has entered an agreement to buy a portfolio of four U.S. pharmaceutical products from Pfizer Inc. Under the deal announced Wednesday, Alvogen plans to acquire three injectable products — Clindamycin, Voriconazole and Melphalan — and one inhaled solution product, Acetylcysteine.
Heartland Food Products Group plans to acquire the Splenda low-calorie sweetener brand from McNeil Nutritionals LLC, a subsidiary of Johnson & Johnson Consumer Inc. Financial terms of the agreement weren’t disclosed. Heartland said the transaction is slated to close before the end of this year.
The National Association of Chain Drug Stores has announced the winners of the 2015 NACDS Total Store Expo Product Showcase.
Amneal Pharmaceuticals LLC has formed Amneal Biosciences, a new business unit.
Ateb Inc. this week kicked off its first branding campaign, dubbed “Driving Healthy Outcomes for Patients, Pharmacies and Payers.
Rusty Field, chief commercial officer at Upsher-Smith Laboratories Inc., has been appointed as president of the company. Upsher-Smith said Monday that in the new role, Field will be responsible for delivering revenue and profitability to meet the pharmaceutical company’s growth objectives.